Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

por Ripoll, Giselle V., Pifano, Marina, Garona, Juan, Alonso, Daniel F.
Publicado 2020

Vasopressin Analog [V(4)Q(5)]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models

por Sobol, Natasha T., Solerno, Luisina M., Llavona, Candela, Alonso, Daniel F., Garona, Juan
Publicado 2023

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells

por Pifano, Marina, Garona, Juan, Capobianco, Carla S., Gonzalez, Nazareno, Alonso, Daniel F., Ripoll, Giselle V.
Publicado 2017

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

por Ripoll, Giselle V., Garona, Juan, Pifano, Marina, Farina, Hernan G., Gomez, Daniel E., Alonso, Daniel F.
Publicado 2013

Preclinical Efficacy of [V(4)Q(5)]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer

por Garona, Juan, Sobol, Natasha T., Pifano, Marina, Segatori, Valeria I., Gomez, Daniel E., Ripoll, Giselle V., Alonso, Daniel F.
Publicado 2019

Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma

por Sobol, Natasha Tatiana, Solernó, Luisina María, Beltrán, Brady, Vásquez, Liliana, Ripoll, Giselle Vanina, Garona, Juan, Alonso, Daniel Fernando
Publicado 2021

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy

por Solernó, Luisina M., Sobol, Natasha T., Gottardo, María F., Capobianco, Carla S., Ferrero, Maximiliano R., Vásquez, Liliana, Alonso, Daniel F., Garona, Juan
Publicado 2022

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization

por Gottardo, Maria F., Capobianco, Carla S., Sidabra, Johanna E., Garona, Juan, Perera, Yasser, Perea, Silvio E., Alonso, Daniel F., Farina, Hernan G.
Publicado 2020

The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target

por Orlando, Ulises D., Garona, Juan, Ripoll, Giselle V., Maloberti, Paula M., Solano, Ángela R., Avagnina, Alejandra, Gomez, Daniel E., Alonso, Daniel F., Podestá, Ernesto J.
Publicado 2012

Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive...

por Segatori, Valeria Inés, Garona, Juan, Caligiuri, Lorena Grisel, Bizzotto, Juan, Lavignolle, Rosario, Toro, Ayelén, Sanchis, Pablo, Spitzer, Eduardo, Krolewiecki, Alejandro, Gueron, Geraldine, Alonso, Daniel Fernando
Publicado 2021

The novel desmopressin analogue [V(4)Q(5)]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models

por GARONA, JUAN, PIFANO, MARINA, ORLANDO, ULISES D., PASTRIAN, MARIA B., IANNUCCI, NANCY B., ORTEGA, HUGO H., PODESTA, ERNESTO J., GOMEZ, DANIEL E., RIPOLL, GISELLE V., ALONSO, DANIEL F.
Publicado 2015

In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma

por Cardama, Georgina A., Bucci, Paula L., Lemos, Jesús S., Llavona, Candela, Benavente, Micaela A., Hellmén, Eva, Fara, María Laura, Medrano, Eduardo, Spitzer, Eduardo, Demarco, Ignacio A., Sabella, Patricia, Garona, Juan, Alonso, Daniel F.
Publicado 2023

Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial

por Iseas, Soledad, Roca, Enrique L., O’Connor, Juan M., Eleta, Martin, Sanchez-Luceros, Analia, Di Leo, Daniela, Tinelli, Marcelo, Fara, Maria L., Spitzer, Eduardo, Demarco, Ignacio A., Ripoll, Giselle V., Pifano, Marina, Garona, Juan, Alonso, Daniel F.
Publicado 2020

A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

por Weinberg, Ruth S, Grecco, Marcelo O, Ferro, Gimena S, Seigelshifer, Debora J, Perroni, Nancy V, Terrier, Francisco J, Sánchez-Luceros, Analía, Maronna, Esteban, Sánchez-Marull, Ricardo, Frahm, Isabel, Guthmann, Marcelo D, Di Leo, Daniela, Spitzer, Eduardo, Ciccia, Graciela N, Garona, Juan, Pifano, Marina, Torbidoni, Ana V, Gomez, Daniel E, Ripoll, Giselle V, Gomez, Roberto E, Demarco, Ignacio A, Alonso, Daniel F
Publicado 2015